Are there any differences in phenotype or disease course between familial and sporadic cases of inflammatory bowel disease?
A family history of IBD does not seem to influence phenotype or to be an important prognostic factor for disease course in IBD patients.
These findings suggest that miR-26b exerts a tumor suppressive role in breast cancer and the miR-26b-mediated growth inhibition is achieved through suppression of a new target gene CDK8.